Hodnocení minimální zbytkové choroby u nemocných s De Novo akutní myeloidní leukemií léčených kombinovanou terapií Azacitidine a Venetoclax.

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	Evaluation of minimal residual disease in patients with De Novo acute myeloid leukemia treated with Azacitidine and Venetoclax combination therapy.
Authors	SEMERÁD Lukáš WEINBERGEROVÁ Barbora PODSTAVKOVÁ N. KVETKOVÁ Anežka MRKVOVÁ Zuzana VOLDŘICH Jakub PROCHÁZKOVÁ Jiřina JEŽÍŠKOVÁ Ivana FOLTA A. BORSKÝ Marek JAROŠOVÁ Marie MAYER Jiří
Year of publication	2023
Type	Conference abstract
MU Faculty or unit	Faculty of Medicine
Citation
Description	Evaluation of minimal residual disease in patients with De Novo acute myeloid leukemia treated with Azacitidine and Venetoclax combination therapy - conference abstract.
Related projects:	National institute for cancer research